Atlas FDA

cobas BRAF v600 Muttaion Test

FDA premarket approval P110020/S032 · decided 2019-05-22

Approval details

PMA number
P110020
Supplement
S032
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
cobas BRAF v600 Muttaion Test
Generic name
Somatic gene mutation detection system
Applicant
Roche Molecular Systems, Inc.
Date received
2019-04-24
Decision date
2019-05-22
Days to decision
28 days
Decision code
OK30
Product code
OWD
Advisory committee
Pathology
Expedited review
No
Location
Pleasanton, CA
Statement
Changes in manufacturing gowning procedures.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
cobas® BV/CV (K260021)Roche Molecular Systems, Inc.2026-07-16
cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the cobas 5800/6800/8800 systems (K260917)Roche Molecular Systems, Inc.2026-07-08
cobas liat CT/NG/MG nucleic acid test (K253759)Roche Molecular Systems, Inc.2026-05-15
cobas liat CT/NG nucleic acid test (K253756)Roche Molecular Systems, Inc.2026-05-15
cobas liat Bordetella panel nucleic acid test (K243753)Roche Molecular Systems, Inc.2025-11-20
cobas CMV (K252481)Roche Molecular Systems, Inc.2025-11-03
cobas HCV (K252484)Roche Molecular Systems, Inc.2025-11-03
cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 Systems (K243455)Roche Molecular Systems, Inc.2025-07-31